All lobbying filings
The KPM Group DC LLC
The KPM Group DC LLC filed a Q4 report for Rocket Pharmaceuticals, Inc. on January 14, 2026, reporting no lobbying activity.
Lobbying for Rocket Pharmaceuticals, Inc. · Pharmaceutical company seeking gene therapy for rare diseases
Filing · LD-2 quarterly report
Q4 reportNo activity
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 14, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbying activity
0
No itemized activity in this filing.